Cannon Financial Strategists’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$431K Sell
1,226
-796
-39% -$284K 0.06% 72
2025
Q4
$662K Hold
2,022
0.09% 54
2025
Q3
$571K Hold
2,022
0.08% 59
2025
Q2
$565K Hold
2,022
0.09% 59
2025
Q1
$630K Sell
2,022
-49
-2% -$14.5K 0.11% 55
2024
Q4
$540K Buy
2,071
+145
+8% +$43K 0.09% 59
2024
Q3
$621K Buy
1,926
+800
+71% +$262K 0.11% 59
2024
Q2
$352K Sell
1,126
-249
-18% -$73.2K 0.07% 66
2024
Q1
$391K Buy
1,375
+175
+15% +$51.2K 0.08% 65
2023
Q4
$346K Hold
1,200
0.07% 66
2023
Q3
$323K Buy
+1,200
New +$299K 0.08% 66

Other funds holding AMGN

Cannon Financial Strategists's AMGN Position: Q1 2026 in Review

Cannon Financial Strategists reduced its Amgen (AMGN) stake by 39% in Q1 2026, selling an estimated $284K and leaving 1,226 shares worth $431K. The position accounts for 0.06% of the portfolio, ranked #72.

Cannon Financial Strategists first reported a position in AMGN in Q3 2023 and has held it in 11 quarters since. The position peaked at $662K in Q4 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Cannon Financial Strategists held 1,226 shares of Amgen worth $431K as of Q1 2026.
  • Cannon Financial Strategists sold 796 Amgen shares in Q1 2026, an estimated $284K.
  • Amgen made up 0.06% of Cannon Financial Strategists's portfolio in Q1 2026, its #72 holding.
  • Cannon Financial Strategists first reported a position in Amgen in Q3 2023 and has held it in 11 quarters since.
  • Cannon Financial Strategists's Amgen position peaked at $662K in Q4 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Cannon Financial Strategists's 13F filing for Q1 2026, filed 12 May 2026.